Skip to main navigation
Skip to search
Skip to main content
Technical University of Munich Home
Help & FAQ
English
Deutsch
Home
Profiles
Research units
Projects
Research output
Datasets
Prizes
Activities
Press/Media
Impacts
Search by expertise, name or affiliation
Ticagrelor or prasugrel in patients with acute coronary syndromes
ISAR-REACT 5 Trial Investigators
Former organisations of the Department of Clinical Medicine
Clinic for Heart and Vascular Diseases
Department of Internal Medicine I - Cardiology
Institute of General Medicine
Partner Site Munich Heart Alliance
Ludwig-Maximilians-Universität München
Technical University of Munich
University Heart Center Freiburg
University Medical Center Ulm and Center of Excellence 'Metabolic Disorders'
Heart Center Bad Segeberg
Giessen University Hospital
Helios Amper-Klinikum Dachau
Universitätsmedizin Mannheim
Partner Site Heidelberg-Mannheim
Klinikum Landkreis Erding
Klinikum der Universität Regensburg und Medizinische Fakultät
Charité – Universitätsmedizin Berlin
Charite Universitätsmedizin Berlin
Partner Site Berlin
Vivantes Auguste-Viktoria-Klinikum
University Hospital Heidelberg
Helios University Hospital Wuppertal
Cardiology
Unit of Gastroenterology SOD2
University of Florida College of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
592
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ticagrelor or prasugrel in patients with acute coronary syndromes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Coronary Syndrome
100%
Ticagrelor
100%
Prasugrel
100%
Myocardial Infarction
37%
Confidence Interval
25%
Hazard Ratio
25%
Stent Thrombosis
25%
Major Bleeding
25%
Invasive Evaluation
25%
Bleeding
12%
Cardiovascular Research
12%
Open-label Trial
12%
ST-segment Elevation
12%
Bleeding Academic Research Consortium
12%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
100%
Ticagrelor
100%
Prasugrel
100%
Heart Infarction
37%
Cerebrovascular Accident
37%
Stent Thrombosis
25%
Bleeding
12%
Open-Label Trial
12%
Biochemistry, Genetics and Molecular Biology
Prasugrel
100%
ST Elevation
12%